Knight Therapeutics | GUD - Nettoeinkommen

Aktienkurs
7.20
Täglich Wechseln
0.12 1.69%
Monatlich
13.56%
Jährlich
18.23%
Q1 Prognose
7.02




Nettoeinkommen Veränderung Datum
Acasti Pharma USD -938K 2.42M 2025-09
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alaunos Therapeutics USD -1.16M 108K 2025-09
Aurora Cannabis CAD 1.82M 53.29M 2025-12
Avita Medical AUD -11.62M 1.7M 2025-12
Canopy Growth CAD -62.63M 60.99M 2025-12
Cronos Group USD -1.82M 24.14M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Moderna USD -200M 625M 2025-09
Omeros USD -32.23M 23.81M 2024-09
Organigram Holdings CAD 19.97M 57.93M 2025-12
Organon & Co USD 160M 15M 2025-09
Revvity USD 98.36M 51.71M 2025-12
Tectonic Therapeutic USD -19.23M 186K 2025-12
Tilray USD -44.93M 44.61M 2025-09
Viatris USD -340.1M 211.9M 2025-12
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12